Providing a combination of treatments for people infected with hepatitis C who inject drugs could help dramatically reduce the risk of liver disease, a new study conducted by researchers at University of Bristol reveals. The findings, published today [24 July], form part of new global recommendations on treating the virus. Around 150 million people globally are chronically infected with the hepatitis C virus (HCV)1 - a major cause of liver disease that ...Saturday, 27 July 2013
Risk of Liver Disease can be Reduced Through Combination Treatments in Hepatitis C Patients Who Inject Drugs
Providing a combination of treatments for people infected with hepatitis C who inject drugs could help dramatically reduce the risk of liver disease, a new study conducted by researchers at University of Bristol reveals. The findings, published today [24 July], form part of new global recommendations on treating the virus. Around 150 million people globally are chronically infected with the hepatitis C virus (HCV)1 - a major cause of liver disease that ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment